Back to results
US 12,636,341 B2Granted
Galectin-targeting immunotherapy
AssigneeVLP Therapeutics, LLC
InventorWataru Akahata
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a virus like particle comprising a viral structural protein and a galectin epitope peptide, and a composition or vaccine comprising thereof, its use in a medicine, particularly in an immunotherapy.
Claims15
A virus like particle comprising an alphavirus viral structural protein and at least one galectin antigen,
- wherein the alphavirus viral structural protein is derived from Chikungunya virus or Venezuelan equine encephalitis virus, and
- wherein the at least one galectin antigen is a peptide fragment of galectin-1 or galectin-3.
Dependencies are inferred from the claim text.